Guanethidine
579
relevant articles (29 outcomes,
48 trials/studies)
found for this Drug
Description:
An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
Also Known As:
((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine; Guanethidine Monosulfate; Guanethidine Sulfate; Guanethidine Sulfate (1:1); Guanethidine Sulfate (1:2); Guanethidine Sulfate (2:1); Guanethidine Sulfate (2:1), 14C-Labeled; Ismelin; Isobarin; Octadine; Oktadin; Monosulfate, Guanethidine; Sulfate, Guanethidine; Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-
Relationship Network
Drug Context: Research Results
Experts
| 1. | Paraskevas, Kosmas I:
2 articles
(09/2006 - 07/2005)
|
| 2. | Samara, Maria:
2 articles
(09/2006 - 07/2005)
|
| 3. | Briana, Despina D:
1 article
(09/2006)
|
| 4. | Michaloglou, Alexandra A:
1 article
(09/2006)
|
| 5. | Trigka, Aikaterini A:
1 article
(07/2005)
|
| 6. | Nozawa, Takashi:
1 article
(08/2003)
|
| 7. | Igawa, Akihiko:
1 article
(08/2003)
|
| 8. | Inoue, Hiroshi:
1 article
(08/2003)
|
| 9. | Asanoi, Hidetsugu:
1 article
(08/2003)
|
| 10. | Fujii, Nozomu:
1 article
(08/2003)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures